Status:
TERMINATED
The Use of Lactobacillus Reuteri in Functional Constipation in Children
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Functional Constipation
Eligibility:
All Genders
6-15 years
Phase:
NA
Brief Summary
Functional constipation (FC) is a common condition in childhood, with an estimated prevalence of 0.7% to 29%.The diagnosis and treatment of FC can be difficult tasks, and children are often referred t...
Detailed Description
Functional constipation (FC) is a common condition in childhood, with an estimated prevalence of 0.7% to 29%.The diagnosis and treatment of FC can be difficult tasks, and children are often referred t...
Eligibility Criteria
Inclusion
- Age 0.5 - 15 years
- Diagnosis of functional constipation according to Rome IV criteria
Exclusion
- Children with chronic diseases which could cause constipation: Celiac disease, food allergy, Hypothyroidism, Inflammatory Bowel Disease, electrolytes disturbances, Cystic fibrosis, Hirschsprung disease, Neuropathic conditions (Spinal cord trauma, Neurofibromatosis, Tethered cord) or intestinal pseudo-obstruction.
- Prematurity (\< 34 weeks)
- S/P intestinal surgery
- Children treated with medications associated with constipation.
- Existing malignancy
- Primary or secondary immunodeficiency
Key Trial Info
Start Date :
June 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 26 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03333070
Start Date
June 26 2018
End Date
June 26 2018
Last Update
October 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emek medical center
Afula, Israel